Suchergebnisse

Covid-19-pandemien har tydeliggjort hvordan grensekryssende helse-trusler har samfunnsmessige konsekvenser. Epidemier ute av kontroll og andre ikke-kontrollerte grensekryssende helsetrusler kan sees som trusler mot fred og sikkerhet. Slike helsekriser kan ha store negative konsekvenser på helse, sosiale forhold og økonomisk utvikling, og har derfor potensiale for å bli både lokale, regionale og globale sikkerhetskriser. Stor ulikhet i tilgang til virkemidler for å kunne håndtere en helsekrise – eksempelvis medisinske mottiltak som vaksiner, legemidler og diagnostikk – kan skape eller forverre ustabilitet og være en sikkerhetsutfordring i seg selv. Med fokus på erfaringer fra covid-19-pandemien vektlegger vi i denne artikkelen global helsesikkerhet som et globalt fellesgode. En økende interesse for grensekryssende helsetrusler i FNs sikkerhetsråd gir muligheter og handlingsrom, men utfordrer også hvordan helsetrusler tolkes og tilnærminger til den internasjonale responsen.
Abstract in English:Outbreaks with Cross-border Potential and the UN Security CouncilThe Covid-19 pandemic has highlighted how outbreaks with cross-border potential have broader macroeconomic consequences. Uncontrolled epidemics and other uncontrolled outbreaks with cross-border potential can be seen as threats to peace and security. Such health crises can have severe consequences for health, social conditions and economic development, and have the potential to impact local, regional and global security. Inequality in access to medical countermeasures, such as vaccines, medicines and diagnostics, can impact or exacerbate instability and be a security threat in itself. Using lessons learned from the covid-19 pandemic, this article emphasizes global health security as a global public good. Increasing interest in outbreaks with cross-border potential in the UN Security Council might open windows of opportunity, but also challenges how global health threats are understood and the international responses to such outbreaks.

We assessed what impact can be expected from global health treaties on the basis of 90 quantitative evaluations of existing treaties on trade, finance, human rights, conflict, and the environment.

Global discussions on universal health coverage (UHC) have focussed attention on the need for increased government funding for health care in many low- and middle-income countries. The objective of this paper is to explore potential targets for government spending on health to progress towards UHC. An explicit target for government expenditure on health care relative to gross domestic product (GDP) is a potentially powerful tool for holding governments to account in progressing to UHC, particularly in the context of UHC's inclusion in the Sustainable Development Goals. It is likely to be more influential than the Abuja target, which requires decreases in budget allocations to other sectors and is opposed by finance ministries for undermining their autonomy in making sectoral budget allocation decisions. International Monetary Fund and World Health Organisation data sets were used to analyse the relationship between government health expenditure and proxy indicators for the UHC goals of financial protection and access to quality health care, and triangulated with available country case studies estimating the resource requirements for a universal health system. Our analyses point towards a target of government spending on health of at least 5% of GDP for progressing towards UHC. This can be supplemented by a per capita target of $86 to promote universal access to primary care services in low-income countries.

Background Innovation through an open source model has proven to be successful for software development. This success has led many to speculate if open source can be applied to other industries with similar success. We attempt to provide an understanding of open source software development characteristics for researchers, business leaders and government officials who may be interested in utilizing open source innovation in other contexts and with an emphasis on drug discovery. Methods A systematic review was performed by searching relevant, multidisciplinary databases to extract empirical research regarding the common characteristics and barriers of initiating and maintaining an open source software development project. Results Common characteristics to open source software development pertinent to open source drug discovery were extracted. The characteristics were then grouped into the areas of participant attraction, management of volunteers, control mechanisms, legal framework and physical constraints. Lastly, their applicability to drug discovery was examined. Conclusions We believe that the open source model is viable for drug discovery, although it is unlikely that it will exactly follow the form used in software development. Hybrids will likely develop that suit the unique characteristics of drug discovery. We suggest potential motivations for organizations to join an open source drug discovery project. We also examine specific differences between software and medicines, specifically how the need for laboratories and physical goods will impact the model as well as the effect of patents.

Background: Intersectoral collaboration is critical to the successful implementation of many public health interventions (PHIs). Little attention has been paid to whether and how processes at the stage of evaluation can promote intersectoral collaboration. The objective of this study was to examine European experiences and views on whether and how the evaluation of PHIs promote intersectoral collaboration. Methods: A qualitative study design was used. We conducted semi-structured interviews with 15 individuals centrally involved in the evaluation of PHIs in 6 European countries (Austria, Denmark, England, Germany, Norway, and Switzerland). Questions pertained to current processes for evaluating PHIs in the country and current and potential strategies for promoting intersectoral collaboration. Transcripts were analyzed using thematic analysis to identify key themes responding to our primary objective. Results: Experiences with promoting intersectoral collaboration through the evaluation of PHIs could be summarized in 4 themes: (1) Early involvement of non-health sectors in the evaluative process and inclusion of non-health benefits can promote intersectoral collaboration, but should be combined with greater influence of these sectors in shaping PHIs; (2) Harmonization of methodological approaches may enable comparison of results and facilitate intersectoral collaboration, but should not be an overriding goal; (3) Involvement in health impact assessments (HIAs) can promote intersectoral collaboration, but needs to be incentivized and be conducted without putting overwhelming demands on non-health sectors; (4) A designated body for evaluating PHIs may promote intersectoral collaboration, but its design needs to take account of realities of policy-making. Conclusion: The full potential for promoting intersectoral collaboration through the evaluation of PHIs appears currently unrealized in the settings we studied. To further promote intersectoral collaboration, evaluators and decisionmakers may consider the full range of strategies characterized in this study. This may be most effective if the strategies are deployed so that they reinforce each other, value outcomes beyond health, and are tailored to maximize political priority for PHIs across sectors.